Somatic cell reprogramming from different origins and donors into iPSC, with four factors OSKM using viral Sendai vectors
Publication date
2025-08
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Notocordal-like cells (NLCs) produced from hiPSCs is considered as a promising candidate for cell-based regenerative therapies to treat intervertebral disk degeneration (IVDD). However, OCT4, SOX2, KLF4, C-MYC (OSKM) reprogramming into iPSC was described to maintain (epi)genomic hallmarks of the origin tissue impacting differentiation abilities. In this context, we produced a three donors-derived unique collection of hiPSCs reprogrammed with OSKM, from two cell types, PBMC and Tie2+ nucleus pulposus-progenitor cells (NPPCs). This collection will allow to further evaluate whether the production of NLCs from iPSCs derived from NPPCs or from PBMC would be the most relevant strategy for hiPSC-based IVDD therapy.
Keywords
Developmental Biology, Cell Biology
Citation
Desprat, R, Magnano, M, Bensadoun, P, Soubeyrand, M, Callier, P, Alle, Q, Bailly, A, Gantenbein, B, Laagland, L T, Tryfonidou, M, Guicheux, J, Camus, A, Milhavet, O & Lemaitre, J M 2025, 'Somatic cell reprogramming from different origins and donors into iPSC, with four factors OSKM using viral Sendai vectors', Stem Cell Research, vol. 86, 103736. https://doi.org/10.1016/j.scr.2025.103736